These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

312 related articles for article (PubMed ID: 15641255)

  • 1. [Thyrotoxicosis due to long-term therapy with interferon alpha in the patient with mixed chronic active hepatitis B and C].
    Vortel J; Bures J; Rejchrt S; Zivný P; Palicka V
    Vnitr Lek; 1999 May; 45(5):301-4. PubMed ID: 15641255
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Treatment of chronic viral hepatitis].
    Pedersen C; Pedersen CR
    Ugeskr Laeger; 2008 Jun; 170(24):2137-40. PubMed ID: 18565297
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Autoimmune lesions of thyroid as complications of interferon treatment of chronic viral hepatitis].
    Ettinger OA; Nikitin IG; Storozhakov GI
    Ter Arkh; 1999; 71(12):69-72. PubMed ID: 10647210
    [No Abstract]   [Full Text] [Related]  

  • 4. Life-threatening severe immune thrombocytopenia during alpha-interferon therapy for chronic hepatitis C.
    Fujii H; Kitada T; Yamada T; Sakaguchi H; Seki S; Hino M
    Hepatogastroenterology; 2003; 50(51):841-2. PubMed ID: 12828100
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment with alpha-interferon in chronic hepatitis.
    Matei I; Tănăsescu C; Voiosu R; Murariu E; Dragomir P; Serbănescu A
    Rom J Intern Med; 1998; 36(3-4):227-37. PubMed ID: 10822519
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Chronic viral hepatitis B and C. Hysteria and panic are no longer appropriate].
    Schwerdtfeger M; Fleig WE
    MMW Fortschr Med; 2000 Nov; 142(46):39-42. PubMed ID: 11132310
    [No Abstract]   [Full Text] [Related]  

  • 7. Thyrotoxicosis induced by alpha-interferon therapy in chronic viral hepatitis.
    Wong V; Fu AX; George J; Cheung NW
    Clin Endocrinol (Oxf); 2002 Jun; 56(6):793-8. PubMed ID: 12072050
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Chronic hepatitis C in a 12-year-old girl coinfected with HGV].
    Szaflarska-Szczepanik A; Loś E; Krenska-Wiacek A; Chrobot A
    Pol Merkur Lekarski; 1999 Jul; 7(37):21-2. PubMed ID: 10522407
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Thyrotoxicosis induced by interferonotherapy of chronic hepatitis C in a woman with Hashimoto's thyroiditis].
    Kozielewicz D; Junik R; Halota W
    Pol Merkur Lekarski; 2014 Aug; 37(218):108-10. PubMed ID: 25252446
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Chronic hepatitis. New therapeutic approaches on trial].
    Kaiser S
    MMW Fortschr Med; 2000 Oct; 142(43):61. PubMed ID: 11098616
    [No Abstract]   [Full Text] [Related]  

  • 11. Systemic lupus erythematosus after alpha-interferon therapy for chronic hepatitis C: a case report and review of the literature.
    Fukuyama S; Kajiwara E; Suzuki N; Miyazaki N; Sadoshima S; Onoyama K
    Am J Gastroenterol; 2000 Jan; 95(1):310-2. PubMed ID: 10638610
    [No Abstract]   [Full Text] [Related]  

  • 12. [Multiple extrahepatic manifestations in a patient with chronic hepatitis C treated with interferon-alfa].
    Napoli N; Tortorella C; Deramo MT; Antonaci A; Parisi CV; Antonaci S
    Recenti Prog Med; 2004 Nov; 95(11):525-8. PubMed ID: 15598090
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of interferon and lamivudine treatment in Japanese patients with HBeAg positive chronic hepatitis B.
    Arase Y; Ikeda K; Suzuki F; Suzuki Y; Kobayashi M; Akuta N; Hosaka T; Sezaki H; Yatsuji H; Kawamura Y; Kobayashi M; Kumada H
    J Med Virol; 2007 Sep; 79(9):1286-92. PubMed ID: 17607775
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is interferon-alpha therapy safe and effective for patients with chronic hepatitis C and inflammatory bowel disease? A case-control study.
    Bargiggia S; Thorburn D; Anderloni A; Ardizzone S; Giorgi A; Bianchi Porro G; Parente F
    Aliment Pharmacol Ther; 2005 Aug; 22(3):209-15. PubMed ID: 16091058
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ophthalmologic side effects during alpha-interferon therapy for viral hepatitis.
    d'Alteroche L; Majzoub S; Lecuyer AI; Delplace MP; Bacq Y
    J Hepatol; 2006 Jan; 44(1):56-61. PubMed ID: 16223542
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Psychosis in a methadone-substituted patient during interferon-alpha treatment of hepatitis C.
    Schäfer M; Boetsch T; Laakmann G
    Addiction; 2000 Jul; 95(7):1101-4. PubMed ID: 10962774
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is steroid therapy needed in the treatment of destructive thyrotoxicosis induced by alpha-interferon in chronic hepatitis C?
    Minelli R; Valli MA; Di Seclì C; Finardi L; Chiodera P; Bertoni R; Ferrari C; Barilli AL; Coiro V; Saccani Jotti G; Delsignore R
    Horm Res; 2005; 63(4):194-9. PubMed ID: 15860921
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Seizures during the treatment with interferon for chronic C hepatitis].
    Anton C; Trifan A; Stanciu C; Stanciu GO; Malgarinos G
    Rev Med Chir Soc Med Nat Iasi; 2000; 104(2):135-7. PubMed ID: 12089978
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Chronic hepatitis and cholangitis. The liver at risk].
    MMW Fortschr Med; 1999 Jun; 141(25):20-1. PubMed ID: 10897899
    [No Abstract]   [Full Text] [Related]  

  • 20. Restless legs syndrome due to interferon-alpha.
    LaRochelle JS; Karp BI
    Mov Disord; 2004 Jun; 19(6):730-1. PubMed ID: 15197722
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.